A correlation between elevated levels of serum FGF23 in rheumatoid arthritis (RA) patients with disease activity and bone resorption has been established [146] because serum RA enhances osteocyte-mediated osteoclastogenesis [28]. Here, FGF23 is linked to rheumatoid arthritis.